Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Daiichi Sankyo
Moodys
AstraZeneca
QuintilesIMS
Boehringer Ingelheim
Merck
Fuji
Cerilliant

Generated: July 18, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 079217

« Back to Dashboard

NDA 079217 describes DRONABINOL, which is a drug marketed by Akorn Inc, Insys Therap, Lannett Co Inc, and Svc Pharma, and is included in four NDAs. It is available from seven suppliers. Additional details are available on the DRONABINOL profile page.

The generic ingredient in DRONABINOL is dronabinol. There are eleven drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the dronabinol profile page.
Summary for 079217
Tradename:DRONABINOL
Applicant:Akorn Inc
Ingredient:dronabinol
Patents:0
Therapeutic Class:Antiemetics
Formulation / Manufacturing:see details
Pharmacology for NDA: 079217
Ingredient-typeCannabinoids
Medical Subject Heading (MeSH) Categories for 079217
Suppliers and Packaging for NDA: 079217
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DRONABINOL dronabinol CAPSULE;ORAL 079217 ANDA Akorn, Inc. 17478-761 N 17478-761-06
DRONABINOL dronabinol CAPSULE;ORAL 079217 ANDA Akorn, Inc. 17478-762 N 17478-762-06

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength2.5MG
Approval Date:Jun 20, 2014TE:ABRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength5MG
Approval Date:Jun 20, 2014TE:ABRLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength10MG
Approval Date:Jun 20, 2014TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
QuintilesIMS
Fish and Richardson
Baxter
Cerilliant
Daiichi Sankyo
Johnson and Johnson
Farmers Insurance
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.